{"id":24324,"date":"2025-07-15T15:58:16","date_gmt":"2025-07-15T13:58:16","guid":{"rendered":"https:\/\/www.investincotedazur.com\/?p=24324"},"modified":"2025-08-07T10:21:50","modified_gmt":"2025-08-07T08:21:50","slug":"caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation","status":"publish","type":"post","link":"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/","title":{"rendered":"Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation"},"content":{"rendered":"\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Caranx Medical,<\/a> a French medtech company based in Nice, has received U.S. FDA clearance for the world\u2019s first AI-powered software for real-time intraoperative guidance during transcatheter aortic valve implantation (TAVI).<\/p>\n\n\n\n

This marks a significant regulatory milestone for Caranx and for France: it is the first time an AI software from a French company has been approved for real-time surgical guidance in a cardiac procedure \u2014 an achievement shared by only a few French medtech firms, such as Quantum Surgical, Bioserenity, and Sublimed.<\/p>\n<\/div>\n<\/div>\n\n\n\n

Backed by Truffle Capital, a major European life sciences investor, and led by a team of seasoned executives and clinical experts, Caranx Medical is developing a robotic and AI-assisted platform to democratize access to complex cardiac valve procedures. Co-founded by Dr. Philippe Pouletty (also Managing Partner at Truffle Capital), Dr. Eric Sejor (CMO), and Pierre Berthet-Rayne (CTO), Caranx aims to become a global leader in robotic TAVI procedures.<\/p>\n\n\n\n

Caranx was established in Nice in 2021 with the support of Team Nice C\u00f4te d\u2019Azur<\/a>, and was a winner of the i-Nov Innovation Contest in the health category.<\/a><\/p>\n\n\n\n

<\/div>\n\n\n\n

A strategic milestone for Caranx Medical<\/h2>\n\n\n\n

The FDA authorization paves the way for commercial launch of TAVIPILOT Soft by the end of 2025.<\/p>\n\n\n

\n
\"\"
(c) Caranx Medical<\/figcaption><\/figure><\/div>\n\n\n
<\/div>\n\n\n\n

A major breakthrough for TAVI procedures<\/h2>\n\n\n\n

\u201cThe FDA approval of TAVIPILOT Soft is a major milestone for the Caranx team,\u201d says Jorgen Hansen, CEO of Caranx. \u201cThis clearance confirms the potential of real-time guidance in TAVI\/TAVR procedures to enhance precision and improve patient outcomes. We are excited to move toward early commercialization by the end of 2025 and to provide interventional teams with a solution that enables safe and predictable valve deployment.\u201d <\/p>\n\n\n\n

<\/div>\n\n\n\n

A growing clinical need and a fast-expanding market<\/h2>\n\n\n\n

TAVI, developed two decades ago, remains a technically demanding procedure with a steep learning curve, requiring high levels of precision. While around 300,000 TAVI procedures are performed annually in the US and EU, 1.7 million patients are currently eligible. According to Frost & Sullivan, the TAVI market is valued at $8 billion annually and continues to grow at a double-digit rate. <\/p>\n\n\n\n

Caranx\u2019s products aim to expand access to TAVI procedures and enable a broader range of interventional cardiology centres to perform them safely.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Expanding AI platform for future cardiovascular indications<\/h2>\n\n\n\n

\u201cAt Caranx Medical, our vision extends to the development of our proprietary artificial intelligence platform, built using data from over 5,000 patients with annotated multimodal imaging (CT, fluoroscopy, echo, data, etc.), which fuels our AI algorithms to revolutionize other cardiovascular indications, such as mitral and tricuspid valve replacements, thereby reshaping the landscape of minimally invasive interventional medicine,\u201d adds Jorgen Hansen, CEO of Caranx.<\/p>\n\n\n\n

<\/div>\n\n\n\n

A mission to save lives and transform medicine<\/h2>\n\n\n\n

\u201cOur mission, as entrepreneurs and company builders, is to save lives and revolutionize medicine. To achieve this, we aim to enable more cardiologists and interventional cardiology centers to perform complex procedures like TAVI, using Caranx\u2019s AI-powered software and autonomous robot,\u201d explains Dr. Philippe Pouletty, founder of Caranx and Managing Partner at Truffle Capital. \u201cWe are exploring ways to make Caranx\u2019s future even more promising and ambitious, particularly through potential collaborations with other cardiovascular medtech companies, as part of an ambitious initiative called CarvOlympics.\u201d <\/p>\n\n\n\n

<\/div>\n\n\n\n

TAVIPILOT Soft: simple, compatible, and AI-powered<\/h2>\n\n\n\n

TAVIPILOT Soft is an easy-to-use, AI-powered intraoperative software that tracks anatomical and instrumental landmarks in real time. It enables clinicians to position the heart valve with precision. <\/p>\n\n\n\n

TAVIPILOT Soft could revolutionize transcatheter aortic valve replacement, which is currently limited to the most experienced cardiologists and surgeons. TAVIPILOT Soft is compatible with all cardiac imaging systems and will support the leading TAVI heart valves on the market. <\/p>\n\n\n\n

Source: Caranx Medical<\/p>\n\n\n\n

<\/div>\n\n\n\n

A thriving health innovation ecosystem in Nice C\u00f4te d\u2019Azur<\/h2>\n\n\n\n

The region\u2019s attractiveness in the health sector is built on a well-structured ecosystem combining cutting-edge infrastructure, academic excellence, and a thriving entrepreneurial environment. The Nice University Hospital (CHU), in partnership with Universit\u00e9 C\u00f4te d\u2019Azur, leads major projects such as IHU RespirERA<\/a>, dedicated to chronic respiratory diseases. Selected in 2023 under the France 2030 programme, this university hospital institute is one of only 12 projects approved at the national level out of over 90 applications, reinforcing Nice\u2019s strategic position in precision medicine and technological innovation. <\/p>\n\n\n\n

This ecosystem also includes the Skin Institute<\/a>, focused on digital dermatology, and 3IA C\u00f4te d\u2019Azur<\/a>, which develops AI applications in healthcare, such as biomarkers, digital twins, and predictive medicine. <\/p>\n\n\n\n

Universit\u00e9 C\u00f4te d\u2019Azur plays a central role in this momentum, notably through the Nucleate France UniCA<\/a> programme, which supports the transition of PhD students into life sciences entrepreneurship. In parallel, the upcoming spin-off Dimicare<\/a>\u2014born from UniCA, INSERM, and CNRS\u2014is developing a new class of targeted antibiotics identified through the ARROW high-throughput screening platform. <\/p>\n\n\n\n

This scientific energy is supported by a network of innovative startups such as Algenscribe<\/a> (genomic medicine), Roca Therapeutics<\/a> (biotechnology), ExAdEx-Innov<\/a> (adipose tissue-based therapies), and Klava Innovation<\/a> (smart medical devices). <\/p>\n\n\n\n

In 2025, Caranx Medical, a medtech company based in Nice, received FDA approval for the first AI software enabling real-time guidance for transcatheter heart valve implantation. This technological breakthrough further strengthens the C\u00f4te d\u2019Azur’s position as a leading hub for digital health and AI-assisted surgery. <\/p>\n\n\n\n

The entire ecosystem benefits from strategic support through Eurobiomed<\/a>, the interregional competitiveness cluster, and enjoys strong international visibility enhanced by strategic partnerships.<\/p>\n","protected":false},"excerpt":{"rendered":"

Caranx Medical, a French medtech company based in Nice, has received U.S. FDA clearance for the world\u2019s first AI-powered software for real-time intraoperative guidance during transcatheter aortic valve implantation (TAVI). This marks a significant regulatory milestone for Caranx and for France: it is the first time an AI software from a French company has been […]<\/p>\n","protected":false},"author":14,"featured_media":23777,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"categories":[143,165,96,138],"tags":[],"acf":[],"yoast_head":"\nCaranx Medical receives FDA clearance for its AI software guiding heart valve implantation - Invest in C\u00f4te d'Azur<\/title>\n<meta name=\"description\" content=\"Caranx Medical receives FDA approval for its AI guiding TAVI heart valve implantation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation - Invest in C\u00f4te d'Azur\" \/>\n<meta property=\"og:description\" content=\"Caranx Medical receives FDA approval for its AI guiding TAVI heart valve implantation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/\" \/>\n<meta property=\"og:site_name\" content=\"Invest in C\u00f4te d'Azur\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-15T13:58:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-07T08:21:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/07\/caranx-medical-TAVIPILOT-Soft.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"700\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jose Perez Gabarron\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Investcotedazur\" \/>\n<meta name=\"twitter:site\" content=\"@Investcotedazur\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jose Perez Gabarron\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/\"},\"author\":{\"name\":\"Jose Perez Gabarron\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/ebbeede4229d29e0861488f2bd1036d9\"},\"headline\":\"Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation\",\"datePublished\":\"2025-07-15T13:58:16+00:00\",\"dateModified\":\"2025-08-07T08:21:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/\"},\"wordCount\":896,\"publisher\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#organization\"},\"articleSection\":[\"Artificial Intelligence\",\"Health\",\"HealthTech\",\"Team C\u00f4te d'Azur\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/\",\"url\":\"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/\",\"name\":\"Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation - Invest in C\u00f4te d'Azur\",\"isPartOf\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#website\"},\"datePublished\":\"2025-07-15T13:58:16+00:00\",\"dateModified\":\"2025-08-07T08:21:50+00:00\",\"description\":\"Caranx Medical receives FDA approval for its AI guiding TAVI heart valve implantation.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#website\",\"url\":\"https:\/\/www.investincotedazur.com\/en\/\",\"name\":\"Invest in C\u00f4te d'Azur\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#organization\"},\"alternateName\":\"Invest in C\u00f4te d'Azur\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.investincotedazur.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#organization\",\"name\":\"Invest in C\u00f4te d'Azur\",\"alternateName\":\"Invest in C\u00f4te d'Azur\",\"url\":\"https:\/\/www.investincotedazur.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2023\/05\/cropped-New-missions-3.png\",\"contentUrl\":\"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2023\/05\/cropped-New-missions-3.png\",\"width\":512,\"height\":512,\"caption\":\"Invest in C\u00f4te d'Azur\"},\"image\":{\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/investincotedazur\/\",\"https:\/\/twitter.com\/Investcotedazur\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/ebbeede4229d29e0861488f2bd1036d9\",\"name\":\"Jose Perez Gabarron\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/20ec9e74f48620b8ee4253da6b114950?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/20ec9e74f48620b8ee4253da6b114950?s=96&d=mm&r=g\",\"caption\":\"Jose Perez Gabarron\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation - Invest in C\u00f4te d'Azur","description":"Caranx Medical receives FDA approval for its AI guiding TAVI heart valve implantation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/","og_locale":"en_US","og_type":"article","og_title":"Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation - Invest in C\u00f4te d'Azur","og_description":"Caranx Medical receives FDA approval for its AI guiding TAVI heart valve implantation.","og_url":"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/","og_site_name":"Invest in C\u00f4te d'Azur","article_published_time":"2025-07-15T13:58:16+00:00","article_modified_time":"2025-08-07T08:21:50+00:00","og_image":[{"width":700,"height":700,"url":"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2025\/07\/caranx-medical-TAVIPILOT-Soft.jpg","type":"image\/jpeg"}],"author":"Jose Perez Gabarron","twitter_card":"summary_large_image","twitter_creator":"@Investcotedazur","twitter_site":"@Investcotedazur","twitter_misc":{"Written by":"Jose Perez Gabarron","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/#article","isPartOf":{"@id":"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/"},"author":{"name":"Jose Perez Gabarron","@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/ebbeede4229d29e0861488f2bd1036d9"},"headline":"Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation","datePublished":"2025-07-15T13:58:16+00:00","dateModified":"2025-08-07T08:21:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/"},"wordCount":896,"publisher":{"@id":"https:\/\/www.investincotedazur.com\/en\/#organization"},"articleSection":["Artificial Intelligence","Health","HealthTech","Team C\u00f4te d'Azur"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/","url":"https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/","name":"Caranx Medical receives FDA clearance for its AI software guiding heart valve implantation - Invest in C\u00f4te d'Azur","isPartOf":{"@id":"https:\/\/www.investincotedazur.com\/en\/#website"},"datePublished":"2025-07-15T13:58:16+00:00","dateModified":"2025-08-07T08:21:50+00:00","description":"Caranx Medical receives FDA approval for its AI guiding TAVI heart valve implantation.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.investincotedazur.com\/en\/caranx-medical-receives-fda-clearance-for-its-ai-software-guiding-heart-valve-implantation\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.investincotedazur.com\/en\/#website","url":"https:\/\/www.investincotedazur.com\/en\/","name":"Invest in C\u00f4te d'Azur","description":"","publisher":{"@id":"https:\/\/www.investincotedazur.com\/en\/#organization"},"alternateName":"Invest in C\u00f4te d'Azur","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.investincotedazur.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.investincotedazur.com\/en\/#organization","name":"Invest in C\u00f4te d'Azur","alternateName":"Invest in C\u00f4te d'Azur","url":"https:\/\/www.investincotedazur.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2023\/05\/cropped-New-missions-3.png","contentUrl":"https:\/\/www.investincotedazur.com\/wp-content\/uploads\/2023\/05\/cropped-New-missions-3.png","width":512,"height":512,"caption":"Invest in C\u00f4te d'Azur"},"image":{"@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/investincotedazur\/","https:\/\/twitter.com\/Investcotedazur"]},{"@type":"Person","@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/ebbeede4229d29e0861488f2bd1036d9","name":"Jose Perez Gabarron","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.investincotedazur.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/20ec9e74f48620b8ee4253da6b114950?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/20ec9e74f48620b8ee4253da6b114950?s=96&d=mm&r=g","caption":"Jose Perez Gabarron"}}]}},"_links":{"self":[{"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/posts\/24324"}],"collection":[{"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/comments?post=24324"}],"version-history":[{"count":2,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/posts\/24324\/revisions"}],"predecessor-version":[{"id":24364,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/posts\/24324\/revisions\/24364"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/media\/23777"}],"wp:attachment":[{"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/media?parent=24324"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/categories?post=24324"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investincotedazur.com\/en\/wp-json\/wp\/v2\/tags?post=24324"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}